Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Asfotase Alfa in Infantile Hypophosphatasia
NCT01205152Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Aug 2016
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Started Apr 2009; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT01205152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205152.